Novo Nordisk enters into partnership with OpenAI for drug development

Novo Nordisk has formed a strategic partnership with OpenAI to integrate artificial intelligence into every stage of its operations, from…

Nothing with $200m to develop AI. Valuation rises to $1.3bn

British electronics manufacturer Nothing has secured $200 million in new capital, raising its valuation to $1.3 billion. The…